Rain Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020	2019
Market Capitalization	44	213	341	-	-
Market Cap Growth	-	-37.66%	-	-	-
Enterprise Value	-33	82	201	-58	-2
PE Ratio	-0.43	-2.81	-6.63	-	-
PB Ratio	0.65	1.88	2.61	-	-
P/FCF Ratio	-0.47	-3.36	-9.07	-	-
P/OCF Ratio	-0.48	-3.36	-9.10	-	-
EV/EBITDA Ratio	0.63	-1.09	-3.92	2.80	0.23
EV/EBIT Ratio	0.63	-1.09	-3.91	2.79	0.23
EV/FCF Ratio	0.68	-1.30	-5.35	5.19	0.22
Debt / Equity Ratio	0.01	0.00	0.00	-0.01	-0.19
Debt / EBITDA Ratio	-0.01	0.00	-0.01	-0.02	-0.31
Debt / FCF Ratio	-0.01	0.00	-0.01	-0.04	-0.29
Quick Ratio	5.34	5.94	8.59	17.22	4.73
Current Ratio	5.58	6.08	8.96	17.41	5.13
Interest Coverage	-	-	-	-155.17	-339.69
Return on Equity (ROE)	-83.00%	-74.40%	-51.60%	77.10%	-
Return on Assets (ROA)	-68.30%	-64.70%	-38.30%	-61.60%	-
Return on Capital (ROIC)	-112.70%	-68.07%	-39.35%	51.29%	77.70%
Earnings Yield	-164.17%	-35.63%	-15.08%	-	-
FCF Yield	-150.97%	-29.74%	-11.03%	-	-
Buyback Yield / Dilution	-36.93%	-44.21%	-478.96%	-38.57%	-
Total Shareholder Return	-36.93%	-44.21%	-478.96%	-38.57%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).